Serge Braun

1.6k total citations
43 papers, 1.0k citations indexed

About

Serge Braun is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Serge Braun has authored 43 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 20 papers in Genetics and 7 papers in Genetics. Recurrent topics in Serge Braun's work include Muscle Physiology and Disorders (18 papers), Virus-based gene therapy research (16 papers) and RNA Interference and Gene Delivery (9 papers). Serge Braun is often cited by papers focused on Muscle Physiology and Disorders (18 papers), Virus-based gene therapy research (16 papers) and RNA Interference and Gene Delivery (9 papers). Serge Braun collaborates with scholars based in France, United States and Switzerland. Serge Braun's co-authors include Jean‐Marie Warter, Philippe Poindron, Bernard Croizat, Achim Walter, Thomas Keller, Tino Colombi, Jon A. Wolff, Christine Thioudellet, Guofeng Zhang and Christine I. Wooddell and has published in prestigious journals such as The Lancet, The Science of The Total Environment and Analytical Biochemistry.

In The Last Decade

Serge Braun

40 papers receiving 960 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serge Braun France 19 647 274 195 163 113 43 1.0k
Ping Fang China 20 650 1.0× 399 1.5× 78 0.4× 51 0.3× 231 2.0× 69 1.2k
Haochuan Li China 19 366 0.6× 178 0.6× 124 0.6× 155 1.0× 102 0.9× 56 1.2k
Daniele dos Santos Martins Brazil 16 344 0.5× 121 0.4× 336 1.7× 313 1.9× 43 0.4× 83 1.0k
Kaori Sakai Japan 21 578 0.9× 179 0.7× 173 0.9× 84 0.5× 30 0.3× 71 1.5k
Adam Rabinowitz United Kingdom 12 934 1.4× 248 0.9× 142 0.7× 62 0.4× 106 0.9× 15 1.1k
Isabelle Martelly France 21 946 1.5× 109 0.4× 118 0.6× 341 2.1× 137 1.2× 65 1.4k
M. Esther Gallardo Spain 20 986 1.5× 174 0.6× 119 0.6× 117 0.7× 89 0.8× 56 1.6k
Kiyoto Ishizeki Japan 20 1.0k 1.6× 241 0.9× 108 0.6× 100 0.6× 59 0.5× 61 1.7k
Jérome Chal United States 11 1.2k 1.8× 153 0.6× 78 0.4× 234 1.4× 144 1.3× 14 1.4k
Naoto Haruyama Japan 24 877 1.4× 233 0.9× 92 0.5× 71 0.4× 37 0.3× 43 1.6k

Countries citing papers authored by Serge Braun

Since Specialization
Citations

This map shows the geographic impact of Serge Braun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serge Braun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serge Braun more than expected).

Fields of papers citing papers by Serge Braun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serge Braun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serge Braun. The network helps show where Serge Braun may publish in the future.

Co-authorship network of co-authors of Serge Braun

This figure shows the co-authorship network connecting the top 25 collaborators of Serge Braun. A scholar is included among the top collaborators of Serge Braun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serge Braun. Serge Braun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Chamberlain, Jeffrey S., Melissa A. Robb, Serge Braun, et al.. (2023). Microdystrophin Expression as a Surrogate Endpoint for Duchenne Muscular Dystrophy Clinical Trials. Human Gene Therapy. 34(9-10). 404–415. 16 indexed citations
4.
Braun, Serge. (2020). Thérapies géniques de l’amyotrophie spinale infantile. médecine/sciences. 36(2). 141–146. 1 indexed citations
5.
Gall, Tony Le, et al.. (2019). Gene transfer to skeletal muscle using hydrodynamic limb vein injection: current applications, hurdles and possible optimizations. The Journal of Gene Medicine. 22(2). e3150–e3150. 14 indexed citations
6.
Braun, Serge. (2019). Biothérapies. médecine/sciences. 35. 8–12.
7.
Colombi, Tino, Serge Braun, Thomas Keller, & Achim Walter. (2016). Artificial macropores attract crop roots and enhance plant productivity on compacted soils. The Science of The Total Environment. 574. 1283–1293. 137 indexed citations
8.
Wooddell, Christine I., Владимир Субботин, Magdolna G. Sebestyén, et al.. (2010). Muscle Damage After Delivery of Naked Plasmid DNA into Skeletal Muscles Is Batch Dependent. Human Gene Therapy. 22(2). 225–235. 31 indexed citations
9.
Zhang, Guofeng, Christine I. Wooddell, Julia Hegge, et al.. (2009). Functional Efficacy of Dystrophin Expression from Plasmids Delivered to mdx Mice by Hydrodynamic Limb Vein Injection. Human Gene Therapy. 21(2). 221–237. 32 indexed citations
10.
Braun, Serge. (2008). Muscular Gene Transfer Using Nonviral Vectors. Current Gene Therapy. 8(5). 391–405. 42 indexed citations
11.
Fardeau, Michel, Serge Braun, Norma B. Romero, et al.. (2005). A propos d'un essai de Phase I de thérapie génique effectué avec un plasmide contenant l'intégralité du gène dystrophine dans la Myopathie de Duchenne/Becker. Journal de la Société de Biologie. 199(1). 29–32. 7 indexed citations
12.
Marchand, Éric, Bruno Constantin, Haouaria Balghi, et al.. (2004). Improvement of calcium handling and changes in calcium-release properties after mini- or full-length dystrophin forced expression in cultured skeletal myotubes. Experimental Cell Research. 297(2). 363–379. 22 indexed citations
13.
Thioudellet, Christine, Stéphane Blot, Patrick Squiban, Michel Fardeau, & Serge Braun. (2002). Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies. Neuromuscular Disorders. 12. S49–S51. 14 indexed citations
14.
Coupin, Gilliane, et al.. (1998). Muscle could be the therapeutic target in SMA treatment. Journal of Neuroscience Research. 53(6). 663–669. 43 indexed citations
16.
Bischoff, Rainer, et al.. (1997). Transfection of Myoblasts in Primary Culture with Isomeric Cationic Cholesterol Derivatives. Analytical Biochemistry. 254(1). 69–81. 11 indexed citations
17.
Kennel, Philippe, et al.. (1995). Myasthenia Gravis: Comparative Autoantibody Assays Using Human Muscle, TE671, and Glucocorticoid-Treated TE671 Cells as Sources of Antigen. Clinical Immunology and Immunopathology. 74(3). 293–296. 5 indexed citations
18.
Braun, Serge, Valerie Askanas, W. King Engel, & Emad Ibrahim. (1993). Long‐Term Treatment with Glucocorticoids Increases Synthesis and Stability of Junctional Acetylcholine Receptors on Innervated Cultured Human Muscle. Journal of Neurochemistry. 60(5). 1929–1935. 24 indexed citations
19.
Vilquin, Jean‐Thomas, Serge Braun, Guy Zuber, et al.. (1992). Specific effect of corticoids on acetylcholine receptor expression in rat skeletal muscle cell cultures. Journal of Neuroscience Research. 31(2). 285–293. 11 indexed citations
20.
Braun, Serge, et al.. (1989). Stimulating effects of prednisolone on acetylcholine receptor expression and myogenesis in primary culture of newborn rat muscle cells. Journal of the Neurological Sciences. 92(2-3). 119–131. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026